164 related articles for article (PubMed ID: 38590418)
1. Inactivation of ERK1/2 in cancer-associated hepatic stellate cells suppresses cancer-stromal interaction by regulating extracellular matrix in fibrosis.
Lin Q; Lei D; Zhong T; Zhang Y; Da Q; Chen X; Li X; Liu J; Yan Z
Am J Cancer Res; 2024; 14(3):1015-1032. PubMed ID: 38590418
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of ERK1/2 in cancer-associated pancreatic stellate cells suppresses cancer-stromal interaction and metastasis.
Yan Z; Ohuchida K; Fei S; Zheng B; Guan W; Feng H; Kibe S; Ando Y; Koikawa K; Abe T; Iwamoto C; Shindo K; Moriyama T; Nakata K; Miyasaka Y; Ohtsuka T; Mizumoto K; Hashizume M; Nakamura M
J Exp Clin Cancer Res; 2019 May; 38(1):221. PubMed ID: 31133044
[TBL] [Abstract][Full Text] [Related]
3. Periostin involved in the activated hepatic stellate cells-induced progression of residual hepatocellular carcinoma after sublethal heat treatment: its role and potential for therapeutic inhibition.
Zhang R; Lin XH; Ma M; Chen J; Chen J; Gao DM; Cui JF; Chen RX
J Transl Med; 2018 Nov; 16(1):302. PubMed ID: 30400797
[TBL] [Abstract][Full Text] [Related]
4. Activated hepatic stellate cells promote hepatocellular carcinoma cell migration and invasion via the activation of FAK-MMP9 signaling.
Han S; Han L; Yao Y; Sun H; Zan X; Liu Q
Oncol Rep; 2014 Feb; 31(2):641-8. PubMed ID: 24284889
[TBL] [Abstract][Full Text] [Related]
5. Hepatocellular carcinoma cells and their fibrotic microenvironment modulate bone marrow-derived mesenchymal stromal cell migration in vitro and in vivo.
Garcia MG; Bayo J; Bolontrade MF; Sganga L; Malvicini M; Alaniz L; Aquino JB; Fiore E; Rizzo MM; Rodriguez A; Lorenti A; Andriani O; Podhajcer O; Mazzolini G
Mol Pharm; 2011 Oct; 8(5):1538-48. PubMed ID: 21770423
[TBL] [Abstract][Full Text] [Related]
6. Hepatic Stellate Cell Modulates the Immune Microenvironment in the Progression of Hepatocellular Carcinoma.
Wang PW; Lin TY; Yang PM; Yeh CT; Pan TL
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142683
[TBL] [Abstract][Full Text] [Related]
7. HSCs-derived COMP drives hepatocellular carcinoma progression by activating MEK/ERK and PI3K/AKT signaling pathways.
Li Q; Wang C; Wang Y; Sun L; Liu Z; Wang L; Song T; Yao Y; Liu Q; Tu K
J Exp Clin Cancer Res; 2018 Sep; 37(1):231. PubMed ID: 30231922
[TBL] [Abstract][Full Text] [Related]
8. Mannan-binding lectin suppresses growth of hepatocellular carcinoma by regulating hepatic stellate cell activation
Li J; Li H; Yu Y; Liu Y; Liu Y; Ma Q; Zhang L; Lu X; Wang XY; Chen Z; Zuo D; Zhou J
Oncoimmunology; 2019; 8(2):e1527650. PubMed ID: 30713782
[TBL] [Abstract][Full Text] [Related]
9. Matrix stiffness modulates hepatic stellate cell activation into tumor-promoting myofibroblasts via E2F3-dependent signaling and regulates malignant progression.
Liu Z; Mo H; Liu R; Niu Y; Chen T; Xu Q; Tu K; Yang N
Cell Death Dis; 2021 Dec; 12(12):1134. PubMed ID: 34873170
[TBL] [Abstract][Full Text] [Related]
10. Hepatic stellate cells activated by acidic tumor microenvironment promote the metastasis of hepatocellular carcinoma via osteopontin.
Song J; Ge Z; Yang X; Luo Q; Wang C; You H; Ge T; Deng Y; Lin H; Cui Y; Chu W; Yao M; Zhang Z; Gu J; Fan J; Qin W
Cancer Lett; 2015 Jan; 356(2 Pt B):713-20. PubMed ID: 25449435
[TBL] [Abstract][Full Text] [Related]
11. CCN1/Cyr61 enhances the function of hepatic stellate cells in promoting the progression of hepatocellular carcinoma.
Li ZQ; Wu WR; Zhao C; Zhao C; Zhang XL; Yang Z; Pan J; Si WK
Int J Mol Med; 2018 Mar; 41(3):1518-1528. PubMed ID: 29286082
[TBL] [Abstract][Full Text] [Related]
12. Hepatic stellate cells and extracellular matrix in hepatocellular carcinoma: more complicated than ever.
Carloni V; Luong TV; Rombouts K
Liver Int; 2014 Jul; 34(6):834-43. PubMed ID: 24397349
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Hepatic Stellate Cell Activation Suppresses Tumorigenicity of Hepatocellular Carcinoma in Mice.
Kang MJ; Lee S; Jung U; Mandal C; Park H; Stetler-Stevenson WG; Kim YS; Moon JW; Park SH; Oh J
Am J Pathol; 2021 Dec; 191(12):2219-2230. PubMed ID: 34428424
[TBL] [Abstract][Full Text] [Related]
14. Myocardin and myocardin-related transcription factor-A synergistically mediate actin cytoskeletal-dependent inhibition of liver fibrogenesis.
Shi Z; Ren M; Rockey DC
Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G504-G517. PubMed ID: 31928221
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of NEK7 Suppressed Hepatocellular Carcinoma Progression by Mediating Cancer Cell Pyroptosis.
Yan Z; Da Q; Li Z; Lin Q; Yi J; Su Y; Yu G; Ren Q; Liu X; Lin Z; Qu J; Yin W; Liu J
Front Oncol; 2022; 12():812655. PubMed ID: 35223495
[TBL] [Abstract][Full Text] [Related]
16. AICAR and compound C negatively modulate HCC-induced primary human hepatic stellate cell activation in vitro.
Böttcher K; Longato L; Marrone G; Mazza G; Ghemtio L; Hall A; Luong TV; Caruso S; Viollet B; Zucman-Rossi J; Pinzani M; Rombouts K
Am J Physiol Gastrointest Liver Physiol; 2021 Apr; 320(4):G543-G556. PubMed ID: 33406006
[TBL] [Abstract][Full Text] [Related]
17. Remodeling of hepatic stellate cells orchestrated the stroma-derived oxaliplatin-resistance through CCN3 paracrine in hepatocellular carcinoma.
Liao X; Bu Y; Chang F; Jia F; Song G; Xiao X; Zhang M; Ning P; Jia Q
BMC Cancer; 2019 Dec; 19(1):1192. PubMed ID: 31805888
[TBL] [Abstract][Full Text] [Related]
18. Combined anti-hepatocellular carcinoma therapy inhibit drug-resistance and metastasis via targeting "substance P-hepatic stellate cells-hepatocellular carcinoma" axis.
Li Z; Wang F; Li Y; Wang X; Lu Q; Wang D; Qi C; Li C; Li Z; Lian B; Tian G; Gao Z; Zhang B; Wu J
Biomaterials; 2021 Sep; 276():121003. PubMed ID: 34273686
[TBL] [Abstract][Full Text] [Related]
19. Deciphering the possible reciprocal loop between hepatic stellate cells and cancer cells in the tumor microenvironment of the liver.
Ezhilarasan D; Najimi M
Crit Rev Oncol Hematol; 2023 Feb; 182():103902. PubMed ID: 36621514
[TBL] [Abstract][Full Text] [Related]
20. PRDM16 from hepatic stellate cells-derived extracellular vesicles promotes hepatocellular carcinoma progression.
Sun C; Xu W; Xia Y; Wang S
Am J Cancer Res; 2023; 13(11):5254-5270. PubMed ID: 38058806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
